辉瑞Hympavzi在欧盟27国及冰岛、列支敦士登和挪威获得全面营销授权

美股速递
May 13

辉瑞公司宣布,其药物Hympavzi的营销授权现已全面覆盖欧盟全部27个成员国,并扩展至冰岛、列支敦士登和挪威。这一授权为相关市场提供了统一的准入许可。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10